Catheter Precision

Catheter Precision EBITDA per Employee

The EBITDA per Employee of Catheter Precision (VTAK) as of Oct 20, 2026 is -1.37 M USD. In the previous year, EBITDA per Employee was -815,071.43 USD — a change of 68.47% (lower).

EBITDA per Employee

-1.37 MUSD

YoY

68.47%

Last updated:

EBITDA per Employee of Catheter Precision is 2025 -1.37 M USD. EBITDA per Employee of Catheter Precision was 2024 -815,071.43 USD. It decreases by 68.47% lower compared to the previous year.

The Catheter Precision EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
-2.23 M USD
Jan 1, 2019
-4.12 M USD
Jan 1, 2020
-2.58 M USD
Jan 1, 2021
-2.09 M USD
Jan 1, 2022
-1.93 M USD
Jan 1, 2023
-5.44 M USD
Jan 1, 2024
-815,071.43 USD
Jan 1, 2025
-1.37 M USD
The Catheter Precision EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-1.37 MUSD+68.47%
-815,071.43USD-85.01%
-5.44 MUSD+182.33%
-1.93 MUSD-7.88%
-2.09 MUSD-18.84%
-2.58 MUSD-37.54%
-4.12 MUSD+85.27%
-2.23 MUSD+75.45%
-1.27 MUSD+323.06%
-299,857.14USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Catheter Precision Stock analysis

What does Catheter Precision do? Ra Medical Systems, Inc. generates revenue through the sale of its electrophysiology products Amigo, VIVO, and LockeT to hospitals, physicians, and healthcare providers. The company's Amigo remote catheter system, featuring an open architecture design, allows for versatile use across multiple catheter procedures. VIVO, a non-invasive 3D imaging system, helps physicians identify arrhythmia origins pre-procedure, improving workflow efficiency. LockeT, a suture retention device, supports surgical procedures. These products target cardiac arrhythmia treatment, serving medical institutions and healthcare professionals seeking advanced solutions for patient care. The firm collaborates with physicians to develop and advance its electrophysiology technologies, focusing on improving cardiac arrhythmia procedures. Its product portfolio addresses the need for streamlined workflows and reduced procedure times in electrophysiology settings. Hospitals and physicians purchase these solutions to enhance patient outcomes and operational efficiency in treating vascular immune-mediated inflammatory diseases. The company's commercialization strategy centers on delivering innovative technologies that meet evolving clinical demands in cardiology. Ra Medical Systems, Inc. is engaged in providing new solutions to the market for cardiac arrhythmia treatment, emphasizing technology development for electrophysiology procedures. Its products are designed to improve patient lives through advanced catheter-based systems and imaging solutions. The company's focus on physician collaboration ensures that its offerings align with clinical needs, driving adoption among healthcare providers specializing in cardiac care. Catheter Precision is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Catheter Precision stock

EBITDA per Employee of Catheter Precision is -1.37 M USD in 2025.

EBITDA per Employee of Catheter Precision changed from -815,071.43 USD to -1.37 M USD, representing a 68.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Catheter Precision since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Catheter Precision historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Catheter Precision

All Key Metrics — Catheter Precision